Navigation Links
Unilens Launches Aspheric C-VUE(R) Daily Disposable Lens
Date:5/21/2008

C-VUE 1 Day ASV Single Vision Lens Now Available Through Licensed Eye Care

Professionals Only

LARGO, Fla., May 21 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF; TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today announced the launch of the all new C-VUE(R) 1 Day ASV, which is the first aspheric, daily disposable contact lens sold under the C-VUE brand.

Unilens, known as the "Eye Care Professional's Specialty Contact Lens Company" continues its tradition of providing outstanding specialty lens solutions exclusively to licensed optical professionals by offering the new C-VUE 1 Day ASV (Aspheric Single Vision) lens as a daily disposable that is ideal for low level astigmats, early presbyopes, and those who simply wish to improve their vision. The new product offering will provide independent practitioners with an additional aspheric C-VUE contact lens option that contributes to patient retention and practice profitability.

C-VUE 1 Day ASV is an easy to fit contact lens, designed with aspheric optics that provides superb comfort and an improved depth of focus at all ranges. There is no required daily cleaning or care required. The lenses may be worn for a day and then just simply thrown away.

"With the continued success of our best selling C-VUE Multifocal lenses, C-VUE Toric Multifocal and C-VUE ASV we are now pleased to offer our very first daily disposable single vision solution with the C-VUE 1 Day ASV to licensed eye professionals only," stated Michael Pecora, Chief Executive Officer of Unilens Vision Inc. "This new offering expands the Company's portfolio of soft lens products, serving the rapidly growing one-time use daily disposable single vision market," concluded Mr. Pecora.

About Unilens Vision Inc. - "The Eye Care Professional's Specialty Contact Lens Company"

Established in 1989, Uni
'/>"/>

SOURCE Unilens Vision Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens
2. Unilens Vision Reports Record First Quarter Earnings and Royalty Income
3. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
4. Unilens Vision Reports 70% Increase in Second Quarter Earnings on Higher Sales and Record Royalty Income
5. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
6. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
7. UPMC Health Plan Launches New Personal Health Record
8. HealthInsuranceFinders.com Launches Video Contest for Young Directors
9. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
10. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
11. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., , DEL MAR, Calif., Nov. 30 /PRNewswire...ration (Pink Sheets: ADHC) is pleased to announce ...dependent director to the Company,s Board of Direc...s over a 40 year period starting at the Chemical B...artner of Harris, Bretall & McEldowney, San Fr...
(Date:11/30/2009)..., , PHILADELPH...l/ -- , - Exclusive Updates From Elsevier...re Reform and ARRA Momentum , Elsevier, a...on as well,as web-based and electronic health reco...ew online resource center for American Recovery an...
(Date:11/30/2009)... The U.S. Centers for Disease Control and Preventi...he United States are infected with HIV/AIDS. New r... that many of those infected are minorities and do...d for a national strategy to facilitate education ...populations. , The research, which analyzed 90,0...
(Date:11/30/2009)... The University of Navarra Hospital has launched a...efficacy of an immunotherapy treatment. This appro...nes produced from healthy and tumour cells from th...ioblastomas, one of the most aggressive and freque...red to participating patients combined with the st...
(Date:11/30/2009)...lder alcoholics tend to drink heavily more often t...NDAY, Nov. 30 (HealthDay News) -- Older people who...eir younger counterparts, a new report finds, poss... same effect. , According to a study released ...der than 60 consume more than 40 drinks a week, on...
Breaking Medicine News(10 mins):Health News:American Diversified Holdings Corporation Announces Appointment of Independent Director to the Board of the Company 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 3Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 4Health News:Research highlights need for national HIV strategy 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:Binge Drinking Not Just a Rite of the Young 2
...P(R),s charitable Sight for Students(R) program an...ception in 1997. The program has funded almost $10...me, uninsured and underinsured children. , , (P...ce, the nation,s largest partnership network worki...
... Treatments , , OTTAWA, March 9 /PRNewswire-First... isotopes and radiopharmaceuticals, today announce...for TheraSphere(R), Yttrium-90 Microsphere (Y-90),...er, faster, and more efficient administration of T...
...d expect to need reading glasses or bifocals durin...ed presbyopia. LASIK, a proven technique for freed...r presbyopia. , , But today, according to result...mpletely eliminated the need for all glasses for 9...
...mex: HH ) today announced that it will release f...before market on Friday, March 13, 2009. The Comp...3, 2009 at 11:00am Eastern Time. , , Conferen...n the Company,s web site located at www.hooperhol...
...f Cosmetic Scientists Meeting , , PROVO, Utah, Ma...nternal free radical generator, age-related NOX (a...ses, Inc. (NYSE: NUS ) links the enzyme to age-r... of Cosmetic Scientists (ASCS), March 2-4, in Yoko...
...Take a Second Look at Patent in a Reexamination Pr... Community , , NEW YORK, March 9 Article One Par...he validity of Merck & Co.,s SINGULAIR U.S. dr...an independent expert join Article One,s opinion t...
Other Medicine News:Health News:VSP's Sight for Students Program Helps 500,000th Child 2Health News:VSP's Sight for Students Program Helps 500,000th Child 3Health News:MDS Nordion Launches Improved TheraSphere(R) Administration System for Physicians 2Health News:MDS Nordion Launches Improved TheraSphere(R) Administration System for Physicians 3Health News:Hooper Holmes Announces Fourth Quarter Earnings Release Date and Conference Call Information 2Health News:Study Links Internal Source of Aging and Skin Damage 2Health News:Study Links Internal Source of Aging and Skin Damage 3Health News:Article One Partners Uncovers New Prior Art Impacting the Validity of Merck's SINGULAIR Patent 2Health News:Article One Partners Uncovers New Prior Art Impacting the Validity of Merck's SINGULAIR Patent 3Health News:Article One Partners Uncovers New Prior Art Impacting the Validity of Merck's SINGULAIR Patent 4
(Date:11/30/2009)...Newswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MED...ical documentation services, today announced that ...ons, Inc. (Nuance) under which MedQuist will now l...ine and processing software for use in SpeechQ of ...recognition application for all medical discipline...
(Date:11/30/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Diabetes Diagnostics - A Global Market ...164347/Diabetes-Diagnostics---A-Global-Market-Pers...driven by a steady increase in the number of peopl...nd developing parts of the world, and increase in ...
(Date:11/30/2009)...-- Dr. Jocelyn Rapelyea, Associate Director of Bre...University Medical Center in Washington, D.C., dem...t-Specific Gamma Imaging (BSGI) can be localized u...as well, as for pre-operative localization today a...f North America (RSNA). ,, BSGI was conducted u...
Breaking Medicine Technology:MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 4Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 5Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 6Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 7Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 8Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 9Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Breast Cancer Numbers Dip Most in Wealthy Urban Areas 50200 1Breast Cancer Numbers Dip Most in Wealthy Urban Areas 50200 2The Psychology of Celebrity Worship 50198 1The Psychology of Celebrity Worship 50198 2The Psychology of Celebrity Worship 50198 3Discus Dental Files Suit to Protect BriteSmile 28R 29 Trademark 50197 1Discus Dental Files Suit to Protect BriteSmile 28R 29 Trademark 50197 2
...June 4 AstraZeneca (NYSE:,AZN) today announced th...n,(sNDA) to the U.S. Food and Drug Administration ...RT(R) (budesonide/formoterol fumarate dihydrate),I...eatment of asthma in,pediatric patients ages 6 to ...the long-term maintenance treatment of asthma in p...
... 4 Semafore Pharmaceuticals Inc.,today reported i...ct,candidate, SF1126, a targeted pan-PI3 kinase (P...mors. SF1126 is the first PI3 kinase inhibitor to ...ltiple myeloma trials., The data from the solid t...ed in a twice-weekly I.V. infusion at exposure lev...
Other Medicine Technology:AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 2AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 3AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 4AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 5AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 6Semafore Pharmaceuticals Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors 2Semafore Pharmaceuticals Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors 3
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: